1. Jiao, Yu-Rui, Wang, Wei, Lei, Peng-Cheng, Wang, Ya-Feng, Zhu, Yi-Kun. 2018. 5-HTT, BMPR2, EDN1, ENG, KCNA5 gene polymorphisms and susceptibility to pulmonary arterial hypertension: A meta-analysis. In Gene, 680, 34-42. doi:10.1016/j.gene.2018.09.020. https://pubmed.ncbi.nlm.nih.gov/30218748/
2. Tian, Li, Liu, Gang, Wang, Le, Zheng, Mingqi, Li, Yongjun. 2015. KCNA5 gene polymorphism associate with idiopathic atrial fibrillation. In International journal of clinical and experimental medicine, 8, 9890-6. doi:. https://pubmed.ncbi.nlm.nih.gov/26309673/
3. Qu, Chao, Sun, Jia, Liu, Ying, Zou, Wei, Liu, Jing. 2018. Caveolin-1 facilitated KCNA5 expression, promoting breast cancer viability. In Oncology letters, 16, 4829-4838. doi:10.3892/ol.2018.9261. https://pubmed.ncbi.nlm.nih.gov/30250548/
4. Wipff, J, Dieudé, P, Guedj, M, Boileau, C, Allanore, Y. . Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. In Arthritis and rheumatism, 62, 3093-100. doi:10.1002/art.27607. https://pubmed.ncbi.nlm.nih.gov/20556823/
5. Ryland, K E, Svoboda, L K, Vesely, E D, Martens, J R, Lawlor, E R. 2014. Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stress. In Oncogene, 34, 4591-600. doi:10.1038/onc.2014.384. https://pubmed.ncbi.nlm.nih.gov/25435365/